HROW Q1 2023 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$26M+18.0% YoY

Gross Profit

$18M68.3% margin

Operating Income

$1M4.6% margin

Net Income

-$7M-25.4% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+28.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$217M

Total Liabilities

$196M

Stockholders' Equity

$22M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$22M	+18.0%
Gross Profit	$18M	$16M	+10.4%
Operating Income	$1M	$2M	-42.4%
Net Income	-$7M	-$2M	-172.5%

Revenue Segments

Other Revenues

$6M100%